In Other News

• Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

• New RNA Detection Tool Shows Promise for HIV and Other Viral Testing

• Molecular Testing Refines Barrett’s Esophagus Progression Risk Beyond Biopsy Findings

• Tissue-Specific Vesicle Isolation Expands Molecular Insights Into Liver Disease

• Agilent Acquisition of Proscia to Advance AI-Enabled Digital Pathology Workflows

• Diazyme Expands Chemistry Testing Portfolio With Alfa Wassermann Acquisition

• Digital Pathology Collaboration Expands Laboratory Access to AI-Driven Diagnostics

• Blood Protein May Help Identify Treatment-Resistant Psychosis

• Electrochemical Biosensor Rapidly Detects Cerebrospinal Fluid Leaks

• FDA Approval Adds Automated Testing Option for Parvovirus B19 Serology

• Whole Genome Sequencing Solution Targets Unsolved Rare Disease Cases

• Updated Digital Pathology Platform Expands AI Integration for Cancer Diagnosis

• Blood Protein Panel Supports Monitoring of Treated Celiac Disease

• Oral and Lung Microbiome Changes Linked to Severe Long Covid Symptoms

• Study Finds Distinct Malaria Parasites Linked to Sickle Cell Trait Protection

• Study Shows How Genome Reference Bias Can Mislead Preventive Testing

• Hemoglobin Levels May Help Signal Long-Term Dementia Risk

• Liquid Biopsy Platform Shows Promise for Early Gynecologic Cancer Detection

• Multi-Omics Study Identifies Blood Marker for MASLD Progression

• Blood-Based Immune Aging Map Could Help Spot Disease Risk Earlier

• Global Survey Finds Pediatric Troponin Testing Lacks Consistent Reference Intervals

• Validated Test Predicts Recurrence Risk and Radiation Benefit in Early-Stage Breast Cancer

• Multi-Cancer Screening Blood Test Gains FDA Breakthrough Designation